Trade problems arise when different maximum residue levels (MRLs) are established for the same compound. This is often interpreted as a difference in the safety evaluation of the residues of the drug. These differences may also result from different agricultural or veterinary practices, different analytes in the monitoring program, or other factors unrelated to the safety assessment. Thus, an important question for deciding the acceptability of an MRL should be whether use of the MRL will result in residues above a country's established acceptable daily intake (ADI). The ADI, rather than the MRL, is the safety standard for the compound because is defined as the amount of residue that can be ingested daily over a consumer's lifetime without appreciable health risk. It is possible to predict whether there is a realistic possibility that uses of a particular MRL will result in a dietary intake that exceeds the ADI. MRLs should be considered "equivalent" for purposes of trade and consumer safety if use of the MRL does not result in residues above a country's ADI. Key Words: Harmonization-Residue-Dietary intake.
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AD1 is based upon a complete review of all available toxicological data. Thus, the AD1 can be considered the safety standard for a compound.
The MRL is normally calculated from the AD1 determined for a particular compound. The residue depletion patterns of a compound in the edible tissues of a particular food animal, good veterinary practices for the use of a drug, and variations in monitoring programs are all factors that may be considered in establishing an MRL.
In some cases, countries or international organizations such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA), using harmonized standards, will arrive at an identical MRL for a particular veterinary compound.
Trade problems can occur when there are differences between countries in the MRLs established for the same compound. This are often interpreted as signifying a toxicologically meaningful difference in the human food safety assessment of the residues of that drug. However, differences in MRLs can also result from differences in the u;se of that compound between countries, in the choice of safety factors, in food consumption factors, or in the analyte or method used in monitoring programs.
Small differences in MRLs, and in some instances larger differences, are likely to be insignificant in terms of their consumer safety. The key question from a regulatory viewpoint is really whether the use of a different MRL will result in dietary residues that exceed a particular country's established safety standard for the compound, the ADI.
A definitive answer to whether an AD1 has been exceeded can come only from dietary intake studies. A dietary intake study determines the actual daily intake of residues by consumers on the basis of laboratory analysis of food commodities in trade or in consumer channels.
Although a dietary intake study is recognized as the preferred and most realistic way of determining dietary exposures to veterinary drug residues, these studies are expensive and time-consuming. They also may not be feasible if the drug has not been in use for some time. Additionally, dietary intake studies are limited to the number of commodities and analytes that can be sampled. Before undertaking actual studies, one should attempt to predict whether there is a realistic possibility that uses of a particular MRL will result in residues above a country's ADI.
One key factor in making predictions about dietary exposure is a knowledge of the amount of edible animal products consumed. The collection of valid food Consumption data is the most difficult problem to overcome before any assessment can be made about the dietary intake of a veterinary drug residue. Patterns of food consumption vary considerably within individuals and groups of individuals. This is particularly true for food consumption data at the international level, where dietary habits are influenced by such factors as ethnic origin, religion, economics, and climate.
In the US., the FDA has traditionally taken a conservative approach to food consumption and considered the 90th percentile consumer when estimating exposure to residues. The 90th percentile consumer eats two to three times more than the 50th percentile consumer.
The 90th and 50th percentile data for edible animal products are shown in Table 1 . These data are from the 1977-1978 Market Research Corporation of America Food Consumption Survey of 1 1 , l SO individuals over a 14-day period. Since the survey reports only the frequency of eating a particular item, it cannot be used independently to deter- Estimates of the dietary intake of veterinary drug residues can be made by use of the guidelines for predicting dietary intake described by Guest and Fitzpatrick (1991) . These guidelines are a modification of those established for predicting the dietary intake of pesticide residues by the Codex Committee on Pesticide Residues (World Health Organization, 1989) .
The pesticide guidelines for predicting dietary exposure start with the most exaggerated predictions and proceed toward more realistic ones. The less realistic predictions are relatively straightforward but give an overestimate of the true residue exposure. However, by starting with the most exaggerated prediction, it is possible to eliminate at an early stage those pesticides whose intake is clearly unlikely to exceed the ADI.
The first step is the theoretical maximum daily intake, or TMDI. It is an estimated of dietary intake calculated using the MRL and the average daily per capita consumption of each food commodity for which an MRL has been established. The TMDI is calculated by multiplying the MRL by the average food consumption for each commodity and then summing the products. In order to compare the TMDI to the ADI, the TMDI is divided by an assumed average body weight of 60 kg.
The TMDI is a gross overestimation of the true pesticide residue intake because: 0 The proportion of crop treated with a pesticide is usually far less than 100%. 0 Very few crops treated with a pesticide contain residues at the MRL level. 0 Residues are normally dissipated during storage, transport, preparation, commercial 0 A large portion of the residue may be discarded upon removal of the inedible portion.
Thus, it cannot not be concluded that an MRL is unacceptable because the TMDI is exceeded. More refined predictions are necessary, However, if the TMDI does not exceed the ADI, it is highly unlikely that an AD1 would be exceeded in actual use of the pesticide.
The estimated maximum daily intake (EMDI) is a more realistic prediction of pesticide residue intake. It is calculated by use of data on the edible portion of the commodity and takes into account the effects of preparation, processing, and cooking of food.
Although the EMDI is a more realistic estimate of true pesticide residue intake than the TMDI, it is still an overestimate because it does not take into account: processing, and cooking of the treated commodity. 0 The proportion of the crop treated is not usually 100%. 0 Very few crops contain residue levels as high as the MRL. Therefore, if the EMDI exceeds the ADI, it will be necessary to try to estimate more closely the true intake.
The estimated daily intake (EDI) takes into account the following factors: 0 Data on food consumption, including subgroups of the population. Known uses of the pesticide. Known residue levels. 0 The proportion of the crop treated. 0 The ratio of the amount of home-grown to imported food. 0 The reduction in the level of pesticide during storage, processing, and cooking.
Since this type of information is usually available only at the national level, ED1 predictions are made on a national basis by those who have adequate information on food consumption, the amount of a given pesticide locally, and the nature and amount of imported food.
This tiered approach to the estimation of dietary intake can also be used for veterinary drugs. For veterinary drugs, the EMDI is calculated by multiplying the MRL by the 90th percentile food consumption data from the species in which the veterinary drug is approved (Guest and Fitzpatrick, 1991) . In order to compare the EMDI with the ADI, the EMDI is divided by the weight of the average person.
The EMDI is an overestimation of the actual veterinary drug residue intake because: 0 In those species in which a veterinary drug is approved, the percentage of animals 0 The 90th percentile eater of a commodity represents the "heavy eater" or meat and Very few edible animal products contain residue at the highest permitted level.
An example of an EMDI calculation using the veterinary drug albendazole is given in Table 2 . Albendazole is an anthelmintic approved for use in cattle. In the U.S., an AD1 for albendazole was calculated from a no-observed-effect level (NOEL) of 5 mgkg from a rat teratology study and the use of a 1,000~ safety factor. The U.S. MRL for total residues of albendazole is 0.6 ppm in muscle and 1.2 ppm in liver, the target tissue. treated is usually far less than 100%. usually consumes 2-3 times more than the 50th percentile consumers. The JECFA evaluated albendazole at its 34th meeting in 1989. The JECFA also used the 5 mgkg NOEL for calculating the AD1 for albendazole. However, the JECFA chose to apply a l00x safety factor for this compound after taking into consideration its poor absorption in humans, its rapid metabolism, the lack of teratogenic potential of most of this metabolites, the use of the drug in humans, and the identity of its residues in food.
A JECFA MRL for total residues of albendazole of 0.1 ppm was established for muscle, fat, and milk. An MRL of 5 ppm for total residues of albendazole in liver and kidney was recommended, based partially on residue depletion patterns and good veterinary practice for that compound.
It is important to note that both the U.S. and the JECFA, after their toxicological assessments, selected the same NOEL from the same study. Differences between the U.S. and JECFA MRLS result from the use of different safety factors and from JECFA's consideration of good veterinary practice. That is, the JECFA chose to consider the practical use of the drug and set MRLs consistent with that use.
In deciding the acceptability of the JECFA MRL from a U.S. perspective, the EMDI will be calculated as follows:
MRL x 90th percentile MRCA food consumption data from approved species 60 kg person EMDI = Using the JECFA MRL for muscle of 0.1 ppm, the EMDI = 0.1 mgkg x 0.155 kg/60 kg = 0.00026 mgkg. This is equivalent to 5.2% of the U.S. AD1 of 0.005 mgkg. Using the JECFA MRL for liver of 5 ppm, the EMDI = 5 mgkg x 0.02 kg/60 kg = 0.0017 mg/kg. This is equivalent to 34% of the U.S. ADI.
To decide the acceptability of the U.S. MRL from a JECFA perspective, the calculation of the EMDI was as follows. Using the U.S. safe concentration for muscle of 0.6 ppm, the EMDI = 0.6 mgkg x 0.155 kg/60 kg = 0.00155 mg/kg. This is equivalent to 3.1% of the JECFA AD1 of 0.05 mgkg. Using the U.S. safe concentration for liver of 1.2 ppm, the EMDI = 1.2 mg/kg x 0.02 kg/60 kg = 0.0004 mgkg. This is equivalent to 0.8% of the JECFA ADI.
These calculations demonstrate that use of either the JECFA or the U.S. MRLs for albendazole will not result in residues above either the JECFA or the U.S. ADIs for that compound. Because extreme values for food consumption have been used in these calculations, it is not appropriate to sum the totals from all edible tissues. To do this, average values for consumption should be used.
In conclusion, before deciding the acceptability of MRLs from a consumer point of view, countries need to take a closer look at the human food safety significance of any differences seen. Comparisons should be made using the ADI, the safety standard for a compound, when a government is deciding whether to accept MRLs established by other countries or international organizations. Harmonization of MRLs can occur primarily in one of two ways. First, each country or organization can adopt the other's MRL, or second, each country or organization determines the other's to be equivalent and accepts the MRL when importing commodities. The former option, clearly preferable because a single number is established, may be difficult to achieve, even with harmonized standards. The second alternative is more easily obtained. MRL could be considered "equivalent" for purposes of trade if use of that MRL does not result in residues above a country's established ADI.
